Name: SYKES & RAY EQUITIES (I) LTD.
Address: 3rd Floor, Cama Building, Dalal St, Kala Ghoda, Fort, Mumbai, 400001, IN
Telephone: 022 6193 7300

Markets

Market Nav

BALANCE SHEET

You can view the balance sheet for the last 5 years.

Pharmaids Pharmaceuticals Ltd.

Dec 04, 02:19 BSE 50.25 (+ 0.30 0.60%)

Volume3866

Prev. Close
49.95

Open Price
48.02

Today's Low / High

48.02 53.19

Bid. Price (Qty.)49.50 (30)

Offer Price (Qty.)
50.25 (20)

52 Wk Low / High

42.00 84.97

Pharmaids Pharmaceuticals Ltd.is not traded in NSE

(₹ in Crs.)

Particulars	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00
No. of Equity Shares (in Lacs)	352.68	352.68	214.86	103.11

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	35.27	35.27	21.44	10.27
Total Share Capital	35.27	35.27	21.44	10.27

Reserves and Surplus	24.05	36.78	0.67	-1.60
Total Reserves and Surplus	24.05	36.78	0.67	-1.60
Money Received Against Share Warrants	0.00	0.00	0.35	0.00
Total Shareholders Funds	59.32	72.05	22.46	8.67
Minority Interest	-4.28	-1.55	0.00	0.00

NON-CURRENT LIABILITIES
Long Term Borrowings	30.18	3.59	0.00	0.00
Other Long Term Liabilities	5.14	5.07	0.00	0.00
Long Term Provisions	0.78	0.62	0.00	0.00
Total Non-Current Liabilities	36.10	9.27	0.00	0.00

CURRENT LIABILITIES
Short Term Borrowings	5.06	1.77	0.00	0.00
Trade Payables	16.32	5.12	1.88	2.31
Other Current Liabilities	7.24	4.61	0.24	0.13
Short Term Provisions	0.10	0.08	0.00	0.00
Total Current Liabilities	28.71	11.58	2.13	2.44

Total Capital And Liabilities	119.85	91.34	24.59	11.11

ASSETS
NON-CURRENT ASSETS
Tangible Assets	44.65	31.46	0.11	0.03
Intangible Assets	0.55	0.55	0.00	0.00
Capital Work-In-Progress	4.53	7.00	2.00	0.45
Fixed Assets	49.73	39.00	2.11	0.48
Goodwill On Consolidation	31.42	31.42	0.00	0.00
Deferred Tax Assets [Net]	10.50	6.67	2.71	0.36
Long Term Loans And Advances	0.00	0.00	1.47	6.19
Other Non-Current Assets	5.90	0.72	0.79	1.42
Total Non-Current Assets	97.55	77.81	7.07	8.44


CURRENT ASSETS
Current Investments	0.00	0.00	3.31	0.00
Inventories	12.18	3.59	0.00	0.89
Trade Receivables	3.13	2.68	1.39	1.34
Cash And Cash Equivalents	2.14	4.80	12.75	0.41
OtherCurrentAssets	4.85	2.46	0.07	0.03
Total Current Assets	22.31	13.53	17.51	2.67

Total Assets	119.85	91.34	24.59	11.11

Particulars	Mar 25
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	10.00
No. of Equity Shares (in Lacs)	352.68

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	35.27
Total Share Capital	35.27
Reserves and Surplus	24.05
Total Reserves and Surplus	24.05
Money Received Against Share Warrants	0.00
Total Shareholders Funds	59.32
Minority Interest	-4.28
NON-CURRENT LIABILITIES
Long Term Borrowings	30.18
Other Long Term Liabilities	5.14
Long Term Provisions	0.78
Total Non-Current Liabilities	36.10
CURRENT LIABILITIES
Short Term Borrowings	5.06
Trade Payables	16.32
Other Current Liabilities	7.24
Short Term Provisions	0.10
Total Current Liabilities	28.71
Total Capital And Liabilities	119.85
ASSETS
NON-CURRENT ASSETS
Tangible Assets	44.65
Intangible Assets	0.55
Capital Work-In-Progress	4.53
Fixed Assets	49.73
Goodwill On Consolidation	31.42
Deferred Tax Assets [Net]	10.50
Long Term Loans And Advances	0.00
Other Non-Current Assets	5.90
Total Non-Current Assets	97.55
CURRENT ASSETS
Current Investments	0.00
Inventories	12.18
Trade Receivables	3.13
Cash And Cash Equivalents	2.14
OtherCurrentAssets	4.85
Total Current Assets	22.31
Total Assets	119.85